Judith Joseph, a New York University psychiatrist and author of the upcoming book “High Functioning: Overcome Your Hidden ...

Depression affects 280 million people worldwide. The mental illness has been proven to lead to changes in eating behavior.

Jackson, Wyoming internal medicine physician Glenn Burnett told political analyst Mark Halperin on Thursday that his patients are struggling with significant mental health issues in the aftermath of ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Machine learning analysis of voice recordings shows promise for detecting depression, with over 70% accuracy, improving ...

Jan. 30, 2025 — Women who go on to develop postpartum depression (PPD) may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood ...

A new review from the Cochrane Database of Systematic Reviews confirms that antidepressants can effectively reduce symptoms ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...

In 2013, the global prevalence of glaucoma was estimated at 64 million people, which rose to 80 million by 2020. Treatments ...

The inhaled mebufotenin candidate, dubbed GH001, was evaluated in the midstage study of 81 patients with treatment-resistant depression. The 40 patients who received GH001 saw an average 15.2 point ...